Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and beauty - Specialized features of Anning Branch of General Hospital of Lanzhou Military Region
Specialized features of Anning Branch of General Hospital of Lanzhou Military Region
Comprehensive treatment of hematological malignancies: standardized and individualized combined chemotherapy and hematopoietic stem cell transplantation are carried out to treat all kinds of hematological malignancies, so that the treatment of myelodysplastic syndromes such as leukemia, lymphoma and myeloma has reached the advanced level in China.

Treatment of hematological diseases with combination of traditional Chinese and western medicine: Optimized application of combination of traditional Chinese and western medicine in the treatment of various hematological diseases, especially the treatment of cytopenia and allergic purpura, has achieved good results.

Standardized treatment of children's acute leukemia: This department is the designated treatment specialty of Shenhua Love Fund, Jackie Chan Fund and other funds, which has effectively reduced the treatment burden of children's leukemia, specially set up a "love ward" for children's hematological diseases, standardized the standardized treatment technology of children's acute leukemia, and made the curative effect of children's leukemia, especially children's acute lymphoblastic leukemia, reach the domestic advanced level.

Hematopoietic stem cell transplantation: This department is the earliest specialist to carry out hematopoietic stem cell transplantation in China, and has become the largest and most advanced clinical stem cell transplantation treatment center in northwest China. He has rich experience in the treatment of malignant hematological diseases and severe aplastic anemia, such as autologous hematopoietic stem cell transplantation and allogeneic hematopoietic stem cell transplantation (matched or semi-matched, related or unrelated, umbilical cord blood, etc.). ) and mixed hematopoietic stem cell transplantation. More than 50 cases are transplanted every year, and the treatment of transplantation technology has reached the leading level in China. In the aspect of stem cell therapy for various intractable diseases, mesenchymal stem cells have been developed to treat cerebral palsy, motor neuron disease and multiple sclerosis in children. Hematopoietic stem cells treat severe hepatitis, liver cirrhosis and diabetic foot. CD34 stem cells have achieved remarkable results in the treatment of traumatic brain injury, nerve injury and osteochondral injury.

Consultation Center for Diagnosis of Difficult Hematological Diseases: Hematological Disease Center is the first unit in Northwest China to carry out leukemia typing and gene matching by flow cytometry. Now it has been able to independently carry out HLA transplantation and matching, leukemia morphology, cytogenetics, immunology and molecular biology diagnosis, hematology fusion oncogene FISH and PCR detection, leukemia minimal residual disease detection, blood coagulation function detection and so on. With the careful consultation of experts in clinical hematology and experimental hematology, the level of disease analysis and diagnosis has been continuously improved.

The only national stem cell treatment center in northwest China-the stem cell treatment center of Lanzhou General Hospital of Lanzhou Military Region was formally established. It is understood that the center was established with the approval of the Ministry of Health of the Military Region on the basis of the Department of Hematology of Lanzhou Military Region General Hospital, one of the two major blood centers of the whole army, the largest blood treatment center in Gansu Province and a member of the hematopoietic stem cell transplantation group of the National Hematology Society.

In order to further promote the development of research and application of stem cell and tumor biotherapy in our province and explore the application technology of stem cell transplantation in the treatment of various tissue injury diseases and tumor biotherapy, with the approval of the Continuing Education Committee of Gansu Provincial Health Department and the Ministry of Health of Lanzhou Military Region, the "Regenerative Medicine-New Progress in Stem Cell Research and Gene" was held on the same day by the General Hospital of Lanzhou Military Region.